Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T Cell selection in mice lacking invariant chain expression

Journal of Experimental Medicine

Volumn 177, Issue 6, 1993, Pages 1699-1712

  Bikoff, Elizabeth K ^a   Huang, Li Yun ^c   Episkopou, Vasso ^b   Meerwijk, Joost Van ^c   Germain, Ronald N ^c   Robertson, Elizabeth J ^a  

^a HARVARD UNIVERSITY   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALPHA CHAIN; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BETA CHAIN; CELL SELECTION; CONTROLLED STUDY; FEMALE; GOLGI COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN TARGETING; SPLEEN CELL; T LYMPHOCYTE;

ANIMAL; ANTIGENS, SURFACE; BIOLOGICAL TRANSPORT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED C57BL; MUTATION; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027309316     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.177.6.1699     Document Type: Article

References (96)

1. Brown, J.H., T. Jardetzky, M.A. Saper, B. Samraoui, P.J. Bjorkman, and D.C. Wiley. 1988. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (Lond.). 332:845.
2. Rudensky, A.Y., P. Preston-Hurlburt, S.C. Hong, A. Barlow, and C. A. Janeway, Jr. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature (Lond.). 353:622.
3. a. Science (Wash. DC). 256:1817.
4. Chicz, R.M., R.G. Urban, W.S. Lane, J.C. Gorga, L.J. Stern, D.A.A. Vignalli, and J.L. Strominger. 1992. Predominant naturally processed peptides bound to FIL A-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature (Lond.). 358:764.
5. Rudensky, A.Y., P. Preston-Hurlburt, B.K. Al-Ramadi, J. Rothbard, and C.A. Janeway, Ji;. 1992. Truncation variants of peptides isolated from MHC class! molecules suggest sequence motifs. Nature (Lond.). 359:429.
6. Jones, P.P., D.B. Murphy, D. Hewgill, and H.O. McDevitt. 1979. Detection of a commqy polypeptide chain in I-A and I-E subregion immunoprecipitates. Mol. Immunol. 16:51.
7. Sung, E., and P.P. Jones. 1981. The invariant chain of murine la antigens: its glycosylation, abundance, and subcellular localization. Mol. Immunol. 18:899.
8. Machamer, C.E., and P. Cresswell. 1982. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.J. Immunol. 129:2564.
9. Kvist, S., K. Wiman, L. Claesson, P.A. Peterson, and B. Dobberstein. 1982. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell. 29:61.
10. β residues responsible for allele-specific cell surface expression. J. Exp Med. 168:823.
11. Teyton, L., D. O’Sullivan, P.W. Dickson, V. Loteau, A. Sette, P. Fink, and P. A. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature (Lond.). 348:39.
12. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S.L. Schmid, V. Quaranta, and P. A. Peterson. 1990. Intracellular transport of class II molecules directed by invariant chain. Nature (Lond.). 348:600.
13. Roche, P.A., M.S. Marks, and P. Cresswell. 1991. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature (Lond.). 354:392.
14. Lamb, C.A., and P. Cresswell. 1992. Assembly and transport properties of invariant chain trimers and HLA-DR invariant chain complexes. J. Immunol. 148:3478.
15. Guagliardi, L.D., B. Koppelman, J.S. Blum, M.S. Marks, P. Cresswell, and F.M. Brodsky. 1990. Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature (Lond.). 343:133.
16. Neefjes, J.J., V. Stollorz, P.J. Peters, H.J. Geuze, and H.L. Ploegh. 1990. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61:171.
17. Lamb, C.A., J.W. Yewdell, J.R. Bennink, and P. Cresswell. 1991. Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc Natl. Acad. Sci. USA. 88:5998.
18. Peters, P.J., J.J. Neefjes, V. Oorschot, H.L. Ploegh, and H.J. Geuze. 1991. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature (Lond.). 349:669.
19. Blum, J.S., and P. Cresswell. 1988. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA. 85:3975.
20. Roche, P.A., and P. Cresswell. 1991. Proteolysis of the class Il-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA. 88:3150.
21. Baake, O., and B. Dobberstein. 1990. MHC class Il-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:707.
22. Roche, P.A., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature (Lond.). 345:615.
23. Roche, P.A., C.L. Teletski, D.R. Karp, V. Pinet, O. Bakke, and E.O. Long. 1992. Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO (Eur. Mol. Biol. Organ.) J. 11:2841.
24. Stern, L.J., and D.C. Wilqr. 1992. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell. 68:465.
25. Miller, J., and R.G. Germain. 1986. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J. Exp Med. 164:1478.
26. Sekaly, R.P., C. Tonnelle, M. Strubin, B. Mach, and E.O. Long. 1986. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain.J Exp Med. 164:1490.
27. aaAg dimers from the endoplasmic reticulum/cis-Golgi compartment. Proc. Natl. Acad. Sci. USA. 88:2346.
28. Anderson, M.S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc Natl. Acad. Sci. USA. 89:2282.
29. Sekaly, R.P., S. Jacobson, J.R. Richert, C. Tonnelle, H.F. McFarland, and E.O. Long. 1988. Antigen presentation to HLA class II-restricted measles virus-specific T cell clones can occur in the absence of the invariant chain. Proc Natl. Acad. Sci. USA. 85:1209.
30. Stockinger, B., U. Pessara, R.H. Lin, J. Habich, M. Grez, and N. Koch. 1989. A role of la-associated invariant chains in antigen processing and presentation. Cell. 56:683.
31. Peterson, M., and J. Miller. 1990. Invariant chain influences the immunological recognition of MHC class II molecules. Nature (Und.). 345:172.
32. Nadimi, F., J. Moreno, F. Momburg, A. Heuser, S. Fuchs, L. Adorini, and GJ. Hammerling. 1991. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Eur. J. Immunol. 21:1255.
33. Bikoff, E.K. 1992. Formation of complexes between self peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens. J. Immunol. 149:1.
34. Peterson, M., and J. Miller. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature (Und.). 357:596.
35. Koch, N., W. Lauer, J. Habicht, and B. Dobberstein. 1987. Primary structure of the gene for the murine Ia antigen-associated invariant chain (II). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence in thyroglobulin. EMBO (Eur. Mol. Biol. Organ.) J. 6:1677.
36. Robertson, E.J. 1991. Using embryonic stem cells to introduce mutations into the mouse germ line. Biol. Reprod. 44:238.
37. Thomas, K.R., and M.R. Capecchi. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 51:503.
38. Mansour, S.L., K.R. Thomas, and M.R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature (Und.). 336:348.
39. Yamamoto, K., N. Koch, M. Steinmetz, and G.J. Hammerling. 1985. One gene encodes two distinct la-associated invariant chains. J. Immunol. 134:3461.
40. Robertson, E.J., A. Bradlqr, M. Kuehn, and M. Evans. 1986. Germline transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature (Uni). 323:445.
41. DeChiara, T.M., A. Efstratiadis, and E.J. Robertson. 1990. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature (Und.). 345:78.
42. Bradley, A. 1987. Production and analysis of chimaeric mice. In Teratocarcinomas and Embryonic Stem Cells: A Practical Approach, E.J. Robertson, editor. IRX Press Ltd., Oxford. 113-151.
43. b haplotype reveal genetic control of isotype expression. J. Immunol. 126:317.
44. Bhattacharya, A., M.E. Dorf, and T.A. Springer. 1981. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J. Immunol. 127:2488.
45. Hammerling, G.J., U. Hammerling, and H. Lemke. 1979. Isolation of twelve monoclonal antibodies against Ia and H-2 antigens: serological characterization and reactivity with B and T lymphocytes. Immunogenetics. 8:433.
46. Murphy, D.B., D. Lo, S. Rath, R.L. Brinster, R.A. Flavell, A. Slanetz, and C.A. Janeway, Jr. 1989. A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature (Uni). 338:765.
47. Janeway, C.J., P.J. Conrad, E.A. Lemer, J. Babich, P. Wettstein, and D.B. Murphy. 1984. Monoclonal antibodies specific for la glycoproteins raised by immunization with activated T cells: possible role of T cell bound la antigens as targets of immunoregulatory T cells. J. Immunol. 132:662.
48. Koch, N., S. Koch, and G. Hammerling. 1982. Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody. Nature (Uni). 299:644.
49. Mehringer, J.H., M.R. Harris, C.S. Kindle, D.W. McCourt, and S.E. Cullen. 1991. Characterization of fragments of the murine la-associated invariant chain. J. Immunol. 146:920.
50. Sant, A.J., L.R. Hendrix, J.E. Coligan, W.L. Maloy, and R.N. Germain. 1991. Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex α/β chains. J. Exp Mel 174:799.
51. Bikoff, E., and B.K. Birshtein. 1986. T cell clones specific for IgG2a of the a allotype: direct evidence for presentation of endogenous antigen. J. Immunol. 137:28.
52. Germain, R.N., and L.R. Hendrix. 1991. MHC class II structure, occupancy, and surface expression determined by postendoplasmic reticulum antigen binding. Nature (Uni). 353:134.
53. Roehm, N.W., P. Marrack, and J.W. Kappler. 1982. Antigen-specific H-2-restricted helper T cell hybridomas. J. Exp Mel 156:191.
54. Glaichenhaus, N., N. Shastri, D.R. Littman, and J.M. Turner. 1991. Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell. 64:511.
55. Landais, D., B.N. Beck, J.M. Buerstedde, S. Degraw, D. Klein, N. Koch, D. Murphy, M. Pierres, T. Tada, D. Yamamoto, C. Benoist, and D. Mathis. 1986. The assignment of chain specificities for anti-la monoclonal antibodies using L cell trans-fectants. J. Immunol. 137:3002.
56. Braunstein, N.S., and R.N. Germain. 1987. Allele-specific control of Ia molecule surface expression and conformation: implications for a general model of Ia structure-function relationships. Proc. Natl. Acad. Sci. USA. 84:2921.
57. Braunstein, N.S., R.N. Germain, K. Loney, and N. Berkowitz. 1990. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution. J. Immunol. 145:1635.
58. Davidson, H.W., P.A. Reid, A. Lanzavecchia, and C. Watts. 1991. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell. 67:105.
59. Sadegh-Nasseri, S., and R.N. Germain. 1991. A role for peptide in determining MHC class II structure. Nature (Und.). 353:167.
60. Neefjes, J.J., and H.L. Ploegh. 1992. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers in endosomes. EMBO (Eur. Mol. Biol. Organ.) J. 11:411.
61. Dornmair, K., B. Rothenhausler, and H.M. McConnell. 1989. Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harbor Symp Quant. Biol. 54:409.
62. Dornmair, K., and H.M. McConnell. 1990. Refolding and reassembly of separate a and β chains of class II molecules of the major histocompatibility complex leads to increased peptide-binding capacity. Proc Natl. Acad. Sci. USA. 87:4134.
63. Rudensky, A.Y., S. Rath, P. Preston-Hurlburt, D.B. Murphy, and C.A. Janeway, Jr. 1991. On the complexity of self. Nature (Lond.). 353:660.
64. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell. 66:1051.
65. + T cells in major histocompatibility complex class 11-deficient mice. Science (Wash. DC). 253:1417.
66. Cosgrove, D., H. Bodmer, M. Bogue, C. Benoist, and D. Mathis. 1992. Evaluation of the functional equivalence of major histocompatibility complex class II A and E complexes.J. Exp Med. 176:629.
67. Guidos, C.J., J.S. Danska, C.G. Fathman, and I.L. Weissman. 1990. T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages. J. Exp Med. 172:835.
68. Germain, R.N., D.M. Bentley, and H. Quill. 1985. Influence of allelic polymorphism on the assembly and surface expression of class II MHC (Ia) molecules. Cell. 43:233.
69. Sant, A.J., and R.N. Germain. 1989. Intracellular competition for component chains determines class II MHC cell surface phenotype. Cell. 57:797.
70. Karp, D.R., C.L. Teletski, D. Jaraquemada, W.L. Maloy, J.E. Coligan, and E.O. Long. 1990. Structural requirements for pairing of α and β chains in HLA-DR and HLA-DP molecules.J Exp. Med. 171:615.
71. Cosson, P., and J.S. Bonifacino. 1992. Role of transmembrane domain interactions in the assembly of class II molecules. Science (Wash. DC). 258:659.
72. Braakman, I., J. Helenius, and A. Helenius. 1992. Role of ATP and disulfide bonds during protein folding in the endoplasmic reticulum. Nature (Lond.). 356:260.
73. Schaiff, W.T., K.A. Hruska, D.W. McCourt, M. Green, and B.D. Schwartz. 1992. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J. Exp Med. 176:657.
74. Townsend, A., T. Elliot, V. Cerundolo, L. Foster, B. Barber, and A. Tse. 1990. Assembly of MHC class I molecules analysed in vitro. Cell. 62:285.
75. Elliott, T., V. Cerundolo, J. Elvin, and A. Townsend. 1991. Peptide-induced conformational change of the class I heavy chain. Nature (Lond.). 351:402.
76. Silver, M.L., K.C. Parker, and D.C. Wiley. 1991. Reconstitution by MHC-restricted peptides of HLA-A2 heavy chain with β2-microglobulin, in vitro. Nature (Lond.). 350:619.
77. Mellins, E., L. Smith, B. Arp, T. Cotner, E. Celis, and D. Pious. 1990. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature (Lond.). 343:71.
78. Ceman, S., R. Rudersdorf, E.O. Long, and R. DeMars. 1992. MHC class II deletion mutant expresses normal levels of transgene encoded class II molecules that have abnormal conformation and impaired antigen presentation ability. J. Immunol. 149:754.
79. Riberdy, J.M., and P. Cresswell. 1992. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J. Immunol. 148:2586.
80. Jensen, P.E. 1990. Regulation of antigen presentation by acidic pH. J. Exp Med. 174:1111.
81. Wettstein, D.A., J.J. Boniface, P.A. Reay, H. Schild, and M.M. Davis. 1991. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J. Exp Med. 174:219.
82. Chen, B.P., A. Madrigal, and P. Parham. 1990. Cytotoxic T cell recognition of an endogenous class IHLA peptide presented by a class II HLA molecule. J. Exp Med. 172:719.
83. Jaraquemada, D., M. Marti, and E.O. Long. 1990. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J. Exp Med. 172:947.
84. Nuchtem, J.G., W.E. Biddison, and R.D. Klausner. 1990. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature (Lond.). 343:74.
85. b antigen. Eur. J. Immunol. 21:1411.
86. Moreno, J., D.A.A. Vignali, F. Nadimi, S. Fuch, L. Adorini, and G.J. Hammerling. 1991. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.J. Immunol. 147:3306.
87. Weiss, S., and B. Bogen. 1992. MHC class II-restricted presentation of intracellular antigen. Cell. 64:767.
88. Nguyen, Q.V., and R. Humphreys. 1989. Time course of intracellular associations, processing, and cleavages of Ii forms and class II major histocompatibility complex molecules.J. Biol. Chem. 264:1631.
89. Marks, M.S., J.S. Blum, and P. Cresswell. 1990. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J. Cell Biol. 111:839.
90. Koch, N., and A.W. Harris. 1984. Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development. J. Immunol. 132:12.
91. Pure, E., K. Inaba, M.T. Crowley, L. Tardelli, M.D. Witmer-Pack, G. Ruberti, G. Fathman, and R.M. Steinman. 1990. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J. Exp Med. 172:1459.
92. Kampgen, E., N. Koch, S. Koch, P. Stoger, C. Heufler, G. Schuler, and N. Romani. 1991. Class II major histocompatibility complex molecules of murine dendritic cells: Synthesis, sialation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proa Natl. Acad. Sci. USA. 88:3014.
93. Collins, T., A.J. Korman, C.T. Wake, J.M. Boss, D.J. Kappes, W. Fiers, K.A. Ault, M.A. Gimbrone, J.L. Strominger, and J.S. Pober. 1984. Immune interferon activates multiple class II major histocompability complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA. 81:4917.
94. Koch, N., G.H.W. Wong, and J.W. Schrader. 1984. Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-y. J. Immunol. 132:1361.
95. Paulnock-King, D., K.C. Sizer, Y.R. Freund, P.P. Jones, and J.R. Parnes. 1985. Coordinate induction of Ia, α, β and Ii mRNA in a macrophage cell line. J. Immunol. 135:632.
96. Polla, B.S., A. Poljak, S.G. Geier, S.G. Nathenson, J. Ohara, W.E. Paul, and L.H. Glimcher. 1986. Three distinct signals can induce class II gene expression in a murine pre-B cell line. Proc. Natl. Acad. Sci. USA. 83:4878.